Lobe Sciences (XCNQ:LOBE) LT-Debt-to-Total-Asset : 21.00 (As of Nov. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lobe Sciences's long-term debt to total assests ratio for the quarter that ended in Nov. 2024 was 21.00.

Lobe Sciences's long-term debt to total assets ratio increased from Nov. 2023 (0.00) to Nov. 2024 (21.00). It may suggest that Lobe Sciences is progressively becoming more dependent on debt to grow their business.

Lobe Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lobe Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences LT-Debt-to-Total-Asset Chart

Lobe Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

4.27

Lobe Sciences Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	0.99	4.27	21.00

Lobe Sciences LT-Debt-to-Total-Asset Calculation

Lobe Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Aug. 2024 is calculated as

LT Debt to Total Assets (A: Aug. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Aug. 2024 )	/	Total Assets (A: Aug. 2024 )
	=	1.106	/	0.259
	=	4.27

Lobe Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Nov. 2024 is calculated as

LT Debt to Total Assets (Q: Nov. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Nov. 2024 )	/	Total Assets (Q: Nov. 2024 )
	=	1.26	/	0.06
	=

Lobe Sciences (XCNQ:LOBE) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lobe Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

LOBEF:USA LOBE:Germany

Address

1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines